R. Bjorkman, CENTRAL ANTINOCICEPTIVE EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND PARACETAMOL - EXPERIMENTAL STUDIES IN THE RAT, Acta anaesthesiologica Scandinavica, 39, 1995, pp. 3-44
Background: These studies were undertaken to investigate the site and
nature of the antinociceptive effect of NSAIDs (Non-Steroidal Anti-Inf
lammatory Drugs) and paracetamol in the central nervous system (CNS).
Methods: Different nociceptive test models were employed: the tail-fli
ck and hot-plate tests (thermoreceptors), the writhing test (visceral
chemoreceptors) the ''scratching, biting, licking'' (SBL) behaviour an
d the colorectal distension test (mechanoreceptors). Drugs were given
intraperitoneally (i.p.), intracerebroventricularly (i.c.v.), intrathe
cally (i.t.) or as local injection via cannulae implanted stereotactic
ally. Nerve destruction was made by local injection of the neurotoxin
5,7-dihydroxytryptamine (5,7-DHT). Whole brain and spinal cord content
s of serotonin and 5-hydroxyindole acetic acid (5-HIAA) were analysed
by high pressure liquid chromatography (HPLC). Results: Injections of
diclofenac induced antinociception in visceral pain models (writhing t
est, colorectal distension test), but not in two models of somatosenso
ry pain (tail-flick and hot-plate test) The antinociceptive effect of
diclofenac (i.p., i.c.v., ol i.t.) was reversed by i.p. naloxone. Nalo
xone also reversed the effect of diclofenac injected locally into thal
amic and hypothalamic areas involved in pain transmission as well as i
n n. paragigantocellularis or n. raphe magnus. In addition, chemical d
estruction of the n. raphe region attenuated the antinociceptive effec
t of diclofenac. Inhibition of serotonergic transmission by pretreatme
nt with methiothepin, ritanserin, parachlorophenylalanine (PCPA) or 5,
7-DHT also reduced the antinociceptive effect of diclofenac in a visce
ral pain model. Pretreatment with diclofenac or ibuprofen blocked pain
behaviour (SBL) after activation of excitatory amino acid receptors o
f the NMDA type, but not pain behaviour after activation of AMPA or su
bstance P (SP) receptors. Paracetamol inhibited hyperalgesia after bot
h NMDA and SP. The antinociceptive effects of diclofenac, ibuprofen an
d paracetamol were reversed by L-arginine, but not by D-arginine. Conc
lusions: The antinociceptive effect of diclofenac involves a central n
ervous component which may be elicited from several defined areas in t
he CNS. Part of the antinociceptive effect seems to be mediated by des
cending inhibitory opioid, serotonin and/or other neurotransmitter sys
tems interfering with visceral pain impulse traffic at the spinal leve
l. NSAIDs and paracetamol interfere with nociception associated with s
pinal NMDA receptor activation. This effect involves an inhibitory act
ion on spinal nitric oxide (NO) mechanisms. Possibly, the supraspinal
antinoceptive effect of NSAIDs may be explained by an analogous action
.